pregnenolone has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kramer, RE; Mason, JI; Rainey, WE; Shay, JW | 1 |
| Sackett, DL; Wolff, J | 1 |
| Hiramatsu, Y; Masuyama, H; Nakamura, K; Nobumoto, E | 1 |
3 other study(ies) available for pregnenolone and paclitaxel
| Article | Year |
|---|---|
The effects of taxol, a microtubule-stabilizing drug, on steroidogenic cells.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Alkaloids; Animals; Bucladesine; Cattle; Cell Line; Cholesterol; Leydig Cells; Male; Mice; Microtubules; Mitochondria; Paclitaxel; Pregnenolone; Progesterone; Steroids; Testicular Neoplasms | 1985 |
Cyclic AMP-independent stimulation of steroidogenesis in Y-1 adrenal tumor cells by antimitotic agents.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Alkaloids; Animals; Cell Line; Cholera Toxin; Colchicine; Cyclic AMP; Demecolcine; Mice; Microtubules; Paclitaxel; Pregnenolone; Protein Kinases; Steroids; Vinblastine | 1986 |
Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Female; Humans; Ketoconazole; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Phthalic Acids; Pregnane X Receptor; Pregnenolone; Receptors, Steroid; RNA, Small Interfering; Signal Transduction | 2016 |